{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:59:29Z","timestamp":1788872369064,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":447,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Brazilian the National Council of Scientific and Technological Development","award":["500992\/2008-8"],"award-info":[{"award-number":["500992\/2008-8"]}]},{"name":"Research Foundation of the State of Rio de Janeiro","award":["E-26\/110305\/2007"],"award-info":[{"award-number":["E-26\/110305\/2007"]}]},{"name":"Research Foundation of the State of Rio de Janeiro","award":["E-26\/110132\/2007"],"award-info":[{"award-number":["E-26\/110132\/2007"]}]},{"name":"Research Foundation of the State of Rio de Janeiro","award":["E-26\/100416\/2007"],"award-info":[{"award-number":["E-26\/100416\/2007"]}]},{"name":"Research Foundation of the State of Rio de Janeiro","award":["E-22\/102733\/2008"],"award-info":[{"award-number":["E-22\/102733\/2008"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.vaccine.2012.03.006","type":"journal-article","created":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T17:48:50Z","timestamp":1331920130000},"page":"3169-3179","source":"Crossref","is-referenced-by-count":9,"title":["The adjuvanticity of Chiococca alba saponins increases with the length and hydrophilicity of their sugar chains"],"prefix":"10.1016","volume":"30","author":[{"given":"Dirlei","family":"Nico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Moreira","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layza Mendes","family":"Brand\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Ferreira","family":"Feij\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele Crespo","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Palatnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio Martins","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Jorge Ribeiro","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisa Beatriz","family":"Palatnik-de-Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.03.006_bib0005","first-page":"1068","article-title":"A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (S\u00e3o Gon\u00e7alo do Amarante, RN)","volume":"19","author":"da Silva","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0010","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1016\/j.vaccine.2008.07.029","article-title":"Immunogenicity assay of the Leishmune\u00ae vaccine against canine visceral leishmaniasis in Brazil","volume":"26","author":"Borja-Cabrera","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0015","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1586\/14760584.7.6.833","article-title":"The FML-vaccine against canine visceral leishmaniasis: from the second generation to the synthetic vaccine","volume":"7","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4269\/ajtmh.1995.52.287","article-title":"Control of zoonotic visceral leishmaniasis. Is it time to change strategies?","volume":"52","author":"Tesh","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4269\/ajtmh.1996.55.125","article-title":"The logic of visceral leishmaniasis control","volume":"55","author":"Dye","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0030","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1016\/j.vaccine.2009.03.045","article-title":"Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune\u00ae in Brazilian endemic areas","volume":"27","author":"Palatnik-de-Sousa","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0035","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.vaccine.2003.11.039","article-title":"Effective Immunotherapy against canine visceral leishmaniasis with the FML-vaccine","volume":"22","author":"Borja-Cabrera","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0040","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1016\/j.vaccine.2007.06.005","article-title":"Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune\u00ae vaccine","volume":"25","author":"Santos","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0045","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/IAI.57.3.754-763.1989","article-title":"Inhibition of Leishmania donovani internalization into murine macrophages by chemically defined parasite glycoconjugate ligands","volume":"57","author":"Palatnik","year":"1989","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0050","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1016\/j.vaccine.2006.02.034","article-title":"Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis","volume":"24","author":"Oliveira-Freitas","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0055","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11101-010-9183-z","article-title":"Saponins as cytotoxic agents: a review","volume":"9","author":"Podolak","year":"2010","journal-title":"Phytochem Rev"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1055\/s-2006-958006","article-title":"Haemolytic time course differences between steroid and triterpenoid saponins","volume":"61","author":"Takechi","year":"1995","journal-title":"Planta Med"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1360-1385(96)80016-1","article-title":"Saponins and plant defense\u2014a soap story","volume":"1","author":"Osbourn","year":"1996","journal-title":"Trends Plant Sci"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0070","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.vaccine.2006.08.035","article-title":"Assessment of the monoterpene, glycidic and triterpene-moieties\u2019 contributions to the adjuvant function of the CP05-saponin of Calliandra pulcherrima Benth","volume":"25","author":"Nico","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0075","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0264-410X(95)00077-E","article-title":"Structure\/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function","volume":"13","author":"Soltysik","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0080","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0264-410X(96)00292-7","article-title":"Haemolytic activities of plant saponins and adjuvants. Effect of Periandra mediterranea saponin on the humoral response to the FML antigen of Leishmania donovani","volume":"15","author":"Santos","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0085","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/j.vaccine.2004.01.072","article-title":"Protective vaccination against murine visceral leishmaniasis using aldehyde-containing Quillaja saponaria sapogenins","volume":"22","author":"Palatnik de Sousa","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0090","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0264-410X(97)00139-4","article-title":"Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicity","volume":"15","author":"R\u00f6nnberg","year":"1997","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.03.006_bib0095","first-page":"285","article-title":"Vaccination against experimental Kala-azar with saponins of Albizia saman (PsAsu and PsAgle) and the FML antigen of Leishmania donovani","volume":"92","author":"Bernardo","year":"1997","journal-title":"MEMIOC"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0100","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.vaccine.2005.07.036","article-title":"Relationship between hemolytic and adjuvant activity and structure of protopanaxadiol-type saponins from the roots of Panax notoginseng","volume":"23","author":"Sun","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.intimp.2005.07.003","article-title":"Structure and biological activity of protopanaxatrioltype saponins from the roots of Panax notoginseng","volume":"6","author":"Sun","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0110","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.vaccine.2009.01.091","article-title":"Advances in saponin-based adjuvants","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0115","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S1359-6446(03)02864-2","article-title":"Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity","volume":"8","author":"Marciani","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0120","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.vaccine.2004.08.022","article-title":"Pulcherrimasaponin, from the leaves of Calliandra pulcherrima, as adjuvant for visceral leishmaniasis","volume":"23","author":"Silva","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0125","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0264-410X(02)00739-9","article-title":"Relationship between adjuvant activity and amphipathic structure of soyasaponins","volume":"21","author":"Oda","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0130","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0264-410X(92)90435-M","article-title":"Adjuvanticity and ISCOM formation by structurally diverse saponins","volume":"10","author":"Bomford","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0135","first-page":"35","article-title":"Structure\/function relationship on adjuvants from Quillaja saponaria Molina","volume":"vol. 92","author":"Kensil","year":"1992"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0140","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1590\/S0103-50532009000900024","article-title":"Two new oleanane saponins from Chiococca alba (L.) Hitch","volume":"20","author":"Borges","year":"2009","journal-title":"J Braz Chem Soc"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0008-6215(95)00278-2","article-title":"Structure of the saponin adjuvant QS-21 and its base-catalyzed isomerization product by 1H and natural abundance 13C NMR spectroscopy","volume":"280","author":"Jacobsen","year":"1996","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0150","series-title":"Interfacial phenomena","author":"Davies","year":"1961"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0155","first-page":"e866","article-title":"Vaccination with the Leishmune\u00ae\u2019s nucleoside hydrolase maps the C-terminal domain as the target of the protective immune response","volume":"4","author":"Nico","year":"2010","journal-title":"PLoS NTD"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0160","first-page":"290","article-title":"Vaccination with the FML antigen (Fucose Mannose Ligand) of Leishmania donovani protects hamsters from experimental visceral leishmaniasis","volume":"46","author":"Palatnik de Sousa","year":"1994","journal-title":"J Braz Soc Adv Sci Ci\u00eancia e Cultura"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0165","unstructured":"The Wilcoxon Signed-Rank Test. Concepts and applications of inferential statistics. Chapter 12a, p. 1. http:\/\/faculty.vassar.edu\/lowry\/webtext.html."},{"key":"10.1016\/j.vaccine.2012.03.006_bib0170","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1016\/j.vaccine.2010.04.034","article-title":"Preclinical evaluation of the synthetic adjuvant SQS-21 and its constituent isomeric saponins","volume":"28","author":"Ragupathi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0175","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/intimm\/8.6.877","article-title":"IFN-gamma is a potent inducer of Ig secretion by sort-purified murine B cells activated through the mIg, but not the CD40, signaling pathway","volume":"8","author":"Snapper","year":"1996","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0180","series-title":"Chemistry and pharmacology of natural products: saponins","article-title":"Saponins","author":"Hostettmann","year":"1995"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0185","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.181.1.387","article-title":"Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis","volume":"181","author":"Murray","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0190","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1084\/jem.185.7.1231","article-title":"Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice","volume":"185","author":"Taylor","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0195","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.4049\/jimmunol.0900276","article-title":"Intracellular replication-deficient Leishmania donovani induces long-lasting protective immunity against visceral leishmaniasis","volume":"183","author":"Selvapandiyan","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0200","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.vaccine.2009.10.053","article-title":"Innate immune defense in visceral leishmaniasis: cytokine mediates protective role by allogeneic effector cells","volume":"28","author":"Manna","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0205","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.145.12.4306","article-title":"Tumor necrosis factor-\u03b1 synergizes with IFN-\u03b3 in mediating killing of Leishmania major through the induction of nitric oxide","volume":"145","author":"Liew","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0210","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.vetimm.2008.11.020","article-title":"Expression of IFN\u03b3, TNF\u03b1, IL-10 and TGF\u03b2 in lymph nodes associates with parasite load and clinical form of disease in dogs naturally infected with Leishmania (Leishmania) chagasi","volume":"128","author":"Alves","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0215","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.vetimm.2008.04.010","article-title":"Longitudinal analysis of cytokine gene expression and parasite load in PBMC in Leishmania infantum experimentally infected dogs","volume":"125","author":"Sanchez-Robert","year":"2008","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0220","first-page":"502","article-title":"Visceral leishmaniasis and anti TNF\u03b1 therapy: case report and review of literature","volume":"27","author":"De Leonardis","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0225","first-page":"247","article-title":"T cell quality in memory and protection implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0230","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1128\/IAI.68.11.6289-6293.2000","article-title":"Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment","volume":"68","author":"Murray","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0235","doi-asserted-by":"crossref","first-page":"e1002279","DOI":"10.1371\/journal.ppat.1002279","article-title":"Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infection","volume":"7","author":"Stanley","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2012.03.006_bib0240","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/rvsc.2000.0419","article-title":"Canine leishmaniasis transmission: higher infectivity amongst naturally infected dogs to sand flies is associated with lower proportions of T helper cells","volume":"69","author":"Guarga","year":"2000","journal-title":"Res Vet Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12003532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12003532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T02:13:50Z","timestamp":1687313630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12003532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":48,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0264410X12003532"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.03.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}